Drug Type Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors), Ionising radiation emitters |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Castration-Resistant Prostatic Cancer | Phase 2 | CA | 01 Jan 2024 | |
Metastatic castration-resistant prostate cancer | Phase 2 | CA | 01 Jan 2024 | |
Prostatic cancer metastatic | Phase 2 | CA | 01 Jan 2024 | |
PSMA-Positive Tumor | Phase 2 | CA | 01 Jan 2024 |